He also shared a version of the presentation his hedge fund Starboard presented to Pfizer officials at a meeting last week. "It's not often that investors and shareholders are able to see what we ...
Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job. Starboard has called on Pfizer’s board to “hold management ...
Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has Johnson & Johnson’s consumer health spinout Kenvue in its sights.
NEW YORK, Oct 22 (Reuters) - Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's (PFE.N), opens new tab board needs to hold management accountable ...
Activist investor Starboard Value could push for Kenvue (NYSE:KVUE) to divest some/all of its "challenged" skin, healthcare and beauty division after a report that the investor has accumulated a ...
Activist investor Starboard Value has sharpened its criticism of Pfizer Inc. (NYSE:PFE), holding the pharmaceutical giant’s management accountable for failing to deliver on its promises of ...
At an investor summit in New York on Tuesday, activist investor Starboard called out Pfizer's PFE board of directors to take action against the latter’s management for making poor capital ...
Oct 20 (Reuters) - Hedge fund Starboard Value has taken a stake in Kenvue (KVUE.N), opens new tab, the consumer products company that makes Band-Aid, Listerine, and Tylenol, and which went public ...
Activist investor Starboard Value has amassed a sizeable stake in Kenvue Inc. (NYSE:KVUE), the consumer-products company that makes Tylenol and Listerine. The exact size of Starboard's stake in ...
Decks & Docks, a 34-year-old Clearwater-based marine construction and outdoor living supply company, has bought a Texas ...
Gabby Jones / Bloomberg via Getty Images Shares of Kenvue (KVUE) took off Monday morning on indications activist investor Starboard Value has taken a large stake in the consumer health products maker.
NEW YORK (Reuters) -Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's board needs to hold management accountable for its underperformance, ...